Sept 12 (Reuters) - Eiger BioPharmaceuticals Inc said on Tuesday it would discontinue a late-stage study testing its experimental drug to treat the most severe form of viral hepatitis. (Reporting by Mariam Sunny in Bengaluru)
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
These proven wealth builders could be exactly what you're searching for right now.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
Here's what could happen next to Microsoft shares.
It's been an "everything buy bonds" bull rally in markets for months, but BofA is cautiously watching a couple of indicators.
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
It's possible to construct a winning long-term investment strategy with just low-cost index funds.
Baron, whose largest position is in Tesla, is betting the new shift in strategy for Tesla’s low-cost car will fill its increasingly empty factories.